Subcutaneous implantable cardioverter-defibrillator therapy in Poland: Results of the Polish S-ICD Registry.
Kempa M, Budrejko S, Tajstra M, Syska P, Lewandowski M, Fabiszak T, Michalak M, Stanek A, Nowak K, Mitkowski P, Kaczmarek K, Orski Z, Janowski M, Szafarz P, Filipecki A, Sokal A, Szołkiewicz M, Jagielski D, Przybylski A.
Kardiol Pol. 2023;81(5):455-462. doi: 10.33963/KP.a2023.0046. Epub 2023 Mar 5.
The extravascular implantable cardioverter-defibrillator: characterization of anatomical parameters impacting substernal implantation and defibrillation efficacy.
Molnár L, Crozier I, Haqqani H, O'Donnell D, Kotschet E, Alison J, Thompson AE, Bhatia VA, Papp R, Zima E, Jermendy Á, Apor A, Merkely B.
Europace. 2022 May 3;24(5):762-773. doi: 10.1093/europace/euab243.
Meta-Analysis of Clinical Outcome After Implantable Cardioverter-Defibrillator Implantation in Patients With Brugada Syndrome.
Dereci A, Yap SC, Schinkel AFL.
JACC Clin Electrophysiol. 2019 Feb;5(2):141-148. doi: 10.1016/j.jacep.2018.09.005. Epub 2018 Nov 1.
Upgrade from implantable cardioverter-defibrillator vs. de novo implantation of cardiac resynchronization therapy: long-term outcomes.
Jędrzejczyk-Patej E, Mazurek M, Kotalczyk A, Kowalska W, Konieczny-Kozielska A, Kozielski J, Podolecki T, Szulik M, Sokal A, Kowalski O, Kalarus Z, Średniawa B, Lenarczyk R.
Europace. 2021 Jan 27;23(1):113-122. doi: 10.1093/europace/euaa339.
Implantation of Implantable Cardioverter Defibrillators in Kazakhstan.
Begisbayev T, Kosherbayeva L, Akhmetov V, Khvan D, Brimzhanova M.
Glob Heart. 2022 May 10;17(1):30. doi: 10.5334/gh.1119. eCollection 2022.
Outcomes of subcutaneous implantable cardioverter-defibrillator implantation in patients on hemodialysis.
Koman E, Gupta A, Subzposh F, Saltzman H, Kutalek SP.
J Interv Card Electrophysiol. 2016 Mar;45(2):219-23. doi: 10.1007/s10840-015-0093-2. Epub 2016 Jan 14.
Characterization of the PRAETORIAN score in Japanese patients undergoing subcutaneous implantable cardioverter-defibrillator implantation.
Yamazaki K, Ishida Y, Sasaki S, Toyama Y, Nishizaki K, Kinjo T, Itoh T, Kimura M, Sakai S, Shikanai S, Sorimachi Y, Hamaura S, Tomita H.
J Cardiol. 2022 Nov;80(5):482-486. doi: 10.1016/j.jjcc.2022.06.014. Epub 2022 Jul 25.
Infection in patients with subcutaneous implantable cardioverter-defibrillator: Results of the S-ICD Post Approval Study.
Gold MR, Aasbo JD, Weiss R, Burke MC, Gleva MJ, Knight BP, Miller MA, Schuger CD, Carter N, Leigh J, Brisben AJ, El-Chami MF.
Heart Rhythm. 2022 Dec;19(12):1993-2001. doi: 10.1016/j.hrthm.2022.07.031. Epub 2022 Aug 6.
The subcutaneous implantable cardioverter-defibrillator in review.
Kamp NJ, Al-Khatib SM.
Am Heart J. 2019 Nov;217:131-139. doi: 10.1016/j.ahj.2019.08.010. Epub 2019 Aug 17.
The implantable cardioverter-defibrillator: An update.
Miller JD, Yousuf O, Berger RD.
Trends Cardiovasc Med. 2015 Oct;25(7):606-11. doi: 10.1016/j.tcm.2015.01.015. Epub 2015 Feb 7.
